Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CELC Celcuity	$49.22 -4.6%	$23.22	$7.57 ▼ $53.85	$1.92B	0.68	582,239 shs	704,332 shs
LFST LifeStance Health Group	$5.35 -1.1%	$4.68	$3.74 ▼ $8.61	$2.08B	1.13	2.01 million shs	2.82 million shs
PGNY Progyny	$22.74 -4.4%	$22.45	$13.39 ▼ $26.76	$1.96B	1.32	1.42 million shs	1.44 million shs
SHCR Sharecare	$1.43	$1.43	$0.48 ▼ $1.44	$531.79M	0.51	2.55 million shs	N/A

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CELC Celcuity	-0.42%	+10.52%	+279.47%	+384.23%	+211.60%
LFST LifeStance Health Group	-0.55%	+18.38%	+28.20%	-7.20%	-4.25%
PGNY Progyny	+1.62%	+9.33%	+8.09%	+8.73%	+13.02%
SHCR Sharecare	0.00%	0.00%	0.00%	0.00%	+3.62%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CELC Celcuity	0.9839 of 5 stars	1.5	2.0	0.0	0.0	2.2	3.3	0.0
LFST LifeStance Health Group	3.2603 of 5 stars	3.4	4.0	0.0	0.0	2.8	2.5	0.6
PGNY Progyny	1.5013 of 5 stars	1.4	2.0	0.0	0.0	3.3	2.5	1.3
SHCR Sharecare	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CELC Celcuity	3.00	Buy	$50.60	2.80% Upside
LFST LifeStance Health Group	2.86	Moderate Buy	$8.50	58.88% Upside
PGNY Progyny	2.73	Moderate Buy	$24.90	9.50% Upside
SHCR Sharecare	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest SHCR, CELC, LFST, and PGNY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/18/2025	CELC Celcuity	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$50.00 ➝ $66.00
8/15/2025	CELC Celcuity	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$74.00 ➝ $70.00
8/8/2025	PGNY Progyny	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$28.00
8/8/2025	LFST LifeStance Health Group	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$8.50 ➝ $9.00
8/8/2025	PGNY Progyny	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$26.00 ➝ $28.00
7/28/2025	CELC Celcuity	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$28.00 ➝ $60.00
7/28/2025	CELC Celcuity	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$27.00 ➝ $50.00
7/28/2025	CELC Celcuity	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$29.00
7/25/2025	LFST LifeStance Health Group	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$8.00
7/17/2025	PGNY Progyny	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$24.00 ➝ $27.00
7/8/2025	PGNY Progyny	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy

(Data available from 8/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CELC Celcuity	N/A	N/A	N/A	N/A	$3.11 per share	N/A
LFST LifeStance Health Group	$1.25B	1.66	$0.04 per share	137.19	$3.78 per share	1.42
PGNY Progyny	$1.24B	1.57	$0.34 per share	67.81	$4.96 per share	4.58
SHCR Sharecare	$445.25M	1.19	N/A	N/A	$1.22 per share	1.17

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CELC Celcuity	-$111.78M	-$3.45	N/A	N/A	N/A	N/A	-126.74%	-60.59%	N/A
LFST LifeStance Health Group	-$57.44M	-$0.05	N/A	N/A	N/A	-1.23%	-1.11%	-0.76%	11/6/2025 (Estimated)
PGNY Progyny	$54.34M	$0.59	38.54	34.98	2.29	4.28%	10.69%	7.12%	N/A
SHCR Sharecare	-$128.50M	-$0.39	N/A	N/A	N/A	-33.64%	-22.81%	-15.96%	N/A

Latest SHCR, CELC, LFST, and PGNY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	CELC Celcuity	-$0.90	-$1.04	-$0.14	-$1.04	N/A	N/A
8/7/2025	Q2 2025	LFST LifeStance Health Group	-$0.03	-$0.01	+$0.02	-$0.01	$345.05 million	$345.31 million
8/7/2025	Q2 2025	PGNY Progyny	$0.42	$0.19	-$0.23	$0.19	$315.70 million	$332.87 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CELC Celcuity	N/A	N/A	N/A	N/A	N/A
LFST LifeStance Health Group	N/A	N/A	N/A	N/A	N/A
PGNY Progyny	N/A	N/A	N/A	N/A	N/A
SHCR Sharecare	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CELC Celcuity	1.14	6.61	6.61
LFST LifeStance Health Group	0.19	1.48	1.48
PGNY Progyny	N/A	2.70	2.70
SHCR Sharecare	N/A	2.02	2.02

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CELC Celcuity	63.33%
LFST LifeStance Health Group	85.50%
PGNY Progyny	94.93%
SHCR Sharecare	35.08%

Insider Ownership

Company	Insider Ownership
CELC Celcuity	15.77%
LFST LifeStance Health Group	6.60%
PGNY Progyny	9.40%
SHCR Sharecare	30.61%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CELC Celcuity	40	38.91 million	32.77 million	Optionable
LFST LifeStance Health Group	10,218	388.94 million	363.27 million	Optionable
PGNY Progyny	310	85.98 million	77.90 million	Optionable
SHCR Sharecare	3,352	371.88 million	258.05 million	Optionable

SHCR, CELC, LFST, and PGNY Headlines

Recent News About These Companies

Sharecare to collaborate with Centers for Medicare & Medicaid Services to improve care quality, accelerate progress in healthcare

July 30, 2025 | globenewswire.com

Sharecare introduces Condition Masterclass to support patient education and health literacy for chronic disease management

July 21, 2025 | globenewswire.com

Sharecare wins 21 Digital Health Awards in Spring 2025 competition

June 23, 2025 | globenewswire.com

Bronstein, Gewirtz & Grossman, LLC Encourages Sharecare Inc. (SHCR) Investors to Inquire about Securities Investigation

June 17, 2025 | accessnewswire.comA

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sharecare Inc. (SHCR) And Encourages Investors to Reach Out

June 15, 2025 | accessnewswire.comA

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sharecare Inc. (SHCR) And Encourages Stockholders to Reach Out

June 12, 2025 | accessnewswire.comA

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sharecare Inc. (SHCR) And Encourages Stockholders to Connect

June 10, 2025 | accessnewswire.comA

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sharecare Inc. (SHCR) and Encourages Shareholders to Learn More About the Investigation

June 8, 2025 | accessnewswire.comA

Sharecare Inc. (SHCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

June 5, 2025 | accessnewswire.comA

Bronstein, Gewirtz & Grossman, LLC Encourages Sharecare Inc. (SHCR) Shareholders to Inquire about Securities Investigation

June 3, 2025 | accessnewswire.comA

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sharecare Inc. (SHCR) And Encourages Shareholders to Connect

June 1, 2025 | accessnewswire.comA

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sharecare Inc. (SHCR) And Encourages Investors to Connect

May 29, 2025 | accessnewswire.comA

Bronstein, Gewirtz & Grossman, LLC Encourages Sharecare Inc. (SHCR) Stockholders to Inquire about Securities Investigation

May 27, 2025 | accessnewswire.comA

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sharecare Inc. (SHCR) and Encourages Investors to Learn More About the Investigation

May 25, 2025 | accessnewswire.comA

Sharecare Inc. (SHCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 22, 2025 | accessnewswire.comA

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sharecare Inc. (SHCR) And Encourages Investors to Connect

May 20, 2025 | accessnewswire.comA

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sharecare Inc. (SHCR) and Encourages Stockholders to Learn More About the Investigation

May 18, 2025 | accessnewswire.comA

Bronstein, Gewirtz & Grossman, LLC Encourages Sharecare Inc. (SHCR) Investors to Inquire about Securities Investigation

May 15, 2025 | accessnewswire.comA

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sharecare Inc. (SHCR) And Encourages Investors to Reach Out

May 13, 2025 | accessnewswire.comA

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sharecare Inc. (SHCR) And Encourages Stockholders to Reach Out

May 11, 2025 | accessnewswire.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHCR, CELC, LFST, and PGNY Company Descriptions

Celcuity NASDAQ:CELC

$49.22 -2.35 (-4.56%)

Closing price 04:00 PM Eastern

Extended Trading

$49.90 +0.68 (+1.38%)

As of 07:05 PM Eastern

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.

LifeStance Health Group NASDAQ:LFST

$5.35 -0.06 (-1.11%)

Closing price 04:00 PM Eastern

Extended Trading

$5.37 +0.02 (+0.37%)

As of 05:30 PM Eastern

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Progyny NASDAQ:PGNY

$22.74 -1.04 (-4.37%)

Closing price 04:00 PM Eastern

Extended Trading

$22.74 0.00 (0.00%)

As of 05:32 PM Eastern

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Sharecare NASDAQ:SHCR

Sharecare, Inc. operates as a digital healthcare platform company. Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being. The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to improve their health and well-being. It also operates RealAge, a platform for health assessment to assess behaviors and existing conditions of its members and provide metric for their physical health. In addition, the company provides secure, automated release of information, audit, and business consulting services to streamline the medical records process for medical facilities. It sells its solutions through direct sales organization and partner relationships. Sharecare, Inc. was founded in 2009 and is headquartered in Atlanta, Georgia.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time